Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Algorhythm Holdings, Inc.RIME · Entity 8356 | INTERIM CFO | September 15, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Algorhythm Holdings, Inc.
Report date September 15, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Expires 2036-09-15 | Direct | 1,144,552 |
Reported balance
After 2026-09-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 1,144,552 · Balance 1,144,552 F1: The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 1,144,552 shares of the Issuer's common stock. The stock option was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. Of the 1,144,552 shares underlying the stock option, 286,138 shares were vested in full on the date of grant and the remaining 858,414 shares vest in equal quarterly installments over a period of two (2) years commencing September 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 1,144,552 shares of the Issuer's common stock. The stock option was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. Of the 1,144,552 shares underlying the stock option, 286,138 shares were vested in full on the date of grant and the remaining 858,414 shares vest in equal quarterly installments over a period of two (2) years commencing September 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Oct 7, 2026 22:20 UTC | Algorhythm Holdings, Inc. RIME · Entity 8356 | GrantStock Option (right to buy) · Derivative | 1,144,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-046182 · ownership.xml · derivative · entry 1 Raele Leticia Adriana · CIK 0002155982 · INTERIM CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,144,552 Underlying: Common Stock · 1,144,552 shares Expires 2036-09-15 F1 · derivative.exercise_price: The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 1,144,552 shares of the Issuer's common stock. The stock option was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. Of the 1,144,552 shares underlying the stock option, 286,138 shares were vested in full on the date of grant and the remaining 858,414 shares vest in equal quarterly installments over a period of two (2) years commencing September 15, 2026. F1 · derivative.exercise_date: The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 1,144,552 shares of the Issuer's common stock. The stock option was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. Of the 1,144,552 shares underlying the stock option, 286,138 shares were vested in full on the date of grant and the remaining 858,414 shares vest in equal quarterly installments over a period of two (2) years commencing September 15, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.